Abstract:Objective This study aimed to analyze the clinical effect of simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy (HIPEC) on synchronous colorectal cancer liver metastasis. Methods 144 patients with synchronous colorectal cancer liver metastasis who were admitted to our hospital from January 2018 to January 2019 were randomly assigned into a control group and an intervention group. The patients in the control group received simultaneous resection of liver metastases. The patients in the intervention group obtained simultaneous resection of liver metastases combined with HIPEC. The recent total effective rate of the two groups was compared, and the disease control rate of the two groups was calculated at 3 months after treatment. The patients were followed up for 3 years. The survival time of the two groups was observed and compared. Fasting venous blood was collected from patients in the two groups, and the carcinoembryonic antigen (CEA) level was compared. The level of quality of life scale (SF-36) and the occurrence of adverse reactions were compared between the two groups. Results The R0 complete resection rate in the intervention group was significantly higher than that in the control group (P < 0.05). The recent total effective rate in the intervention group (87.50%) was significantly higher than that in the control group (59.72%) (P < 0.05). The negative change of CEA in the intervention group was 72.22%, which was prominently higher than that in the control group of 43.06% (χ 2 =12.542, P<0.001). Following a 36-month follow-up, the overall survival rate of the observation group was significantly higher than that of the control group [HR=2.54(1.05~5.48), P<0.001]. The patients in the intervention group had significantly higher life quality scores of health status, social function, emotional function, physical function, and mental health than the control group (P < 0.05). There was no significant difference in the incidence of complications between the two groups (P > 0.05). Age > 60 years, preoperative comorbidities, moderate and high differentiation of tumors, intraoperative blood loss > 150ml and less experienced surgeons were risk factors affecting the occurrence of complications after treatment, and were closely correlated with the prognosis and survival of patients (P < 0.05). Patients with age ≤ 60 years, no preoperative comorbidities, low tumor differentiation, intraoperative blood loss ≤ 150ml, more experienced surgeons and complete R0 resection had a longer survival time. Age > 60 years, preoperative comorbidities, moderate and high differentiation of tumors, intraoperative blood loss > 150ml and less experienced surgeons were independent risk factors affecting the prognosis of patients with colorectal cancer liver metastases (P < 0.05), while R0 surgery was an independent protective factor for the prognosis (P < 0.05). Conclusion In the treatment of synchronous colorectal cancer liver metastases, simultaneous resection of liver metastases in conjunction with HIPEC demonstrated superior efficacy. This approach may potentially extend patient survival and enhance quality of life, and deserve to be extensively used in clinical practice.

The treatment strategy of R0 resection in colorectal cancer with synchronous para-aortic lymph node metastasis

Multi-Center, Randomized, Controlled, Open-Label Effectiveness Study Of Primary Tumor Resection Or Not In Asymptomatic Colorectal Cancer With Unresectable Metastatic Disease.

A Novel Scoring System Predicting Survival Benefits of Palliative Primary Tumor Resection for Patients with Unresectable Metastatic Colorectal Cancer: A Retrospective Cohort Study Protocol.

Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients

Prognostic impact of para-aortic lymph node dissection in colorectal cancer patients suspected of para-aortic lymph node metastasis: A retrospective cohort study

Prospective single-arm multicenter interventional study of surgical resection for liver metastasis f cancer; 3-year overall and recurrence-free survival

Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients

[Analysis of Long-Term Outcomes and Risk Factors in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastasis].

Para-Aortic Lymph Node Dissection for Patients with Node-Negative Cervical Squamous Cell Carcinoma: A Retrospective Cohort Study

Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis

Feasibility of Pancreaticoduodenectomy with Synchronous Liver Metastasectomy for Oligometastatic Pancreatic Ductal Adenocarcinoma - A Case-Control Study

Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer

Prognostic Analysis of Surgical Resection for Patients with Liver Metastases from Gastric Cancer

Surgical strategy for synchronous colorectal liver metastases

Prognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers

Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes

Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment.

Determinants Of Long-Term Outcome In Patients Undergoing Simultaneous Resection Of Synchronous Colorectal Liver Metastases

Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence

Does adjuvant treatment improve survival in R1 resected perihilar cholangiocarcinoma? The risk of overtreatment

Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?